Back to User profile » Professor Zhen-Yu He

Papers published by Professor Zhen-Yu He:


Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial

Chen Y, Li WX, Wu JH, Chen GH, Yang CM, Lu H, Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Hong RX, Jiang KK, Zhong YY, Zhang G, Tienchaiananda P, Oikawa M, Yuan ZY, Chen QJ

Breast Cancer: Targets and Therapy 2024, 16:223-231

Published Date: 12 April 2024

Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients

Long ZQ, Hua X, Zhang WW, Lv SW, Deng JP, Guo L, He ZY, Lin HX

Cancer Management and Research 2019, 11:4809-4814

Published Date: 27 May 2019

Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer

Wu SG, Zhang WW, Wang J, Dong Y, Chen YX, He ZY

OncoTargets and Therapy 2019, 12:2071-2078

Published Date: 19 March 2019

Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study

Zhang WW, Wu SG, Ling YH, Sun JY, Long ZQ, Hua X, Dong Y, Li FY, He ZY, Lin HX

Cancer Management and Research 2018, 10:4509-4515

Published Date: 11 October 2018

Long-term survival effect of the interval between mastectomy and radiotherapy in locally advanced breast cancer

Zhang WW, Wu SG, Sun JY, Li FY, He ZY

Cancer Management and Research 2018, 10:2047-2054

Published Date: 16 July 2018

Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3

Zhou J, Zhang WW, Peng F, Sun JY, He ZY, Wu SG

Cancer Management and Research 2018, 10:535-544

Published Date: 19 March 2018

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer

Wu SG, Zhang WW, He ZY, Sun JY, Wang Y, Zhou J

Cancer Management and Research 2017, 9:813-819

Published Date: 11 December 2017

Sites of metastasis and overall survival in esophageal cancer: a population-based study

Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L

Cancer Management and Research 2017, 9:781-788

Published Date: 6 December 2017

The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix

Zhou J, Zhang WW, Wu SG, He ZY, Sun JY, Wang Y, Chen QH

Cancer Management and Research 2017, 9:315-322

Published Date: 18 July 2017

Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study

Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y

OncoTargets and Therapy 2016, 9:6569-6572

Published Date: 25 October 2016

Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database

Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY

OncoTargets and Therapy 2016, 9:6435-6444

Published Date: 19 October 2016

Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry

Zhou J, Sun JY, Chen SY, Li FY, Lin HX, Wu SG, He ZY

OncoTargets and Therapy 2016, 9:67-73

Published Date: 23 December 2015

Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma

Qin J, Wu SG, Sun JY, Lin HX, He ZY, Li Q

OncoTargets and Therapy 2015, 8:947-953

Published Date: 23 April 2015